G01N 2333/7153
Or colony-stimulating factors [csf]
Official title: or colony-stimulating factors [CSF]
G01N2333/7153 (Or colony-stimulating factors [csf]) appears on 6 US grants and 16 published applications in this corpus.
Search patents in G01N- Granted patents
- 6
- Published applications
- 16
- Assignees
- 11
- Inventors
- 28
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 2 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 2 | 1 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of treating disorders using CSFIR inhibitors24 Mar 2026US 12,582,655 B2Deciphera Pharmaceuticals, LLC
- Methods of treating disorders using CSF1R inhibitors2 Dec 2025US 12,485,120 B2Deciphera Pharmaceuticals, LLC
- Methods of treating disorders using CSF1R inhibitors29 Apr 2025US 12,285,430 B2Deciphera Pharmaceuticals, LLC
- Methods of treating disorders using CSF1R inhibitors20 Jun 2023US 11,679,110 B2Deciphera Pharmaceuticals, LLC
- Methods of treating disorders using CSF1R inhibitors31 Aug 2021US 11,103,507 B2Deciphera Pharmaceuticals, LLC
- Methods of treating disorders using csf1r inhibitors20 Aug 2026US 2026/0240849 A1Deciphera Pharmaceuticals, LLC
- Methods of treating disorders using csf1r inhibitors23 Jul 2026US 2026/0207601 A1Deciphera Pharmaceuticals, LLC
- Methods of predicting and treating immunotherapy adverse events based on immune cell populations16 Jul 2026US 2026/0202406 A1Board of Regents, The University of Texas System
- Methods of treating disorders using csf1r inhibitors5 Feb 2026US 2026/0034131 A1Deciphera Pharmaceuticals, LLC
- Methods of treating disorders using csf1r inhibitors26 Jun 2025US 2025/0205237 A1Deciphera Pharmaceuticals, LLC
Most cited
By later US patents
- Methods of treating disorders using CSF1R inhibitors50US 11,103,507 B2Deciphera Pharmaceuticals, LLC · 2021
- Methods of treating disorders using CSF1R inhibitors27US 11,679,110 B2Deciphera Pharmaceuticals, LLC · 2023
- Methods of treating disorders using CSF1R inhibitors8US 12,285,430 B2Deciphera Pharmaceuticals, LLC · 2025
- Methods of treating disorders using CSFIR inhibitors2US 12,582,655 B2Deciphera Pharmaceuticals, LLC · 2026
- Methods of treating disorders using CSF1R inhibitors1US 12,485,120 B2Deciphera Pharmaceuticals, LLC · 2025